Source:
Generated By: https://synbiohub.org/public/igem/igem2sbol/1
Created by: Hao Wang
Date created: 2015-09-01 11:00:00
Date modified: 2015-09-07 09:02:02
hTERT+tRNA Composite
| Types | DnaRegion |
| Roles | engineered_region Composite |
| Sequences | BBa_K1722010_sequence (Version 1) |
Description
Targeted therapy has become the fastest growing subject in research on cancer treatment. Telomerase, which serves as the tumor marker, is activated in most malignancy while it's negatively expressed in normal cells. Because of the high expression of human telomerase reverse transcriptase(hTERT) gene in telomerase positive cancer cells, researchers construct plasmids with hTERT promoter and effector gene to target at cancer cells and kill them. It has been proved that hTERT can regulate the activation and expression of telomerase in transcription level. Research shows that hTERT promoter is rich in GC but lack of TATA box or CAAT box. It's also methylated and deacetylated in different level. We construct hTERT promoter and tRNA in the same plasmid to produce tRNA. In the unnatural amino acid orthogonal system that we are constructing, hUPll promoter and hTERT promoter can recognise bladder specific RNA polymerase and tumor specific RNA polymerase, respectively. Only when the two promoters are activated simultanuously can both AckRS and tRNA be produced. In this way, Ack can be attached to tRNA that perfectly pair with the mRNA chain to express the protein.Notes
Both hTERT promoter and tRNA are achieved from Shenzhen Second People's Hospital. We designed primers and amplified the gene sequences from psi-Check2 vector. Using 3A Assembly method, we constructed hTERT and tRNA in pSB1C3.Source
Both hTERT promoter and tRNA are achieved from Shenzhen Second People's Hospital.| Access | Instance | Definition |
| public public | BBa_K1722002 BBa_K1722004 | BBa_K1722002 aa-tRNA |
| Sequence Annotation | Location | Component / Role(s) |
| BBa_K1722002 BBa_K1722004 | 1,454 463,534 | BBa_K1722002 aa-tRNA |